Compounds > pentetic acid

pentetic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

pentetic acid has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (17.14)18.2507
2000's15 (42.86)29.6817
2010's13 (37.14)24.3611
2020's1 (2.86)2.80

Authors

AuthorsStudies
Hnatowich, DJ; Virzi, F; Wu, C1
Beeley, NR; Boyce, RA; Chaplin, L; Cox, JP; Craig, AS; Harrison, A; Jankowski, KJ; Parker, D; Sansom, JM; Walker, CA1
Boden, J; Boden, R; Boyce, B; Farnsworth, AP; King, DJ; Millar, K; Millican, TA; Pedley, RB; Rhind, SK; Turner, A1
DeNardo, GL; DeNardo, SJ; Fand, I; Kroger, LA; Kukis, DL; Meares, CF; Miers, LA; Renn, O; Salako, Q; Shen, S1
Bakker, WH; Béhé, M; Bernard, BF; Breeman, WA; De Jong, M; Hofland, LJ; Krenning, EP; Mäcke, HR; Schmidt, M; Srinivasan, A; Visser, TJ1
Chinol, M; Cremonesi, M; Ferrari, M; Grana, C; Paganelli, G; Prisco, G; Robertson, C; Stabin, MG; Tosi, G1
Norrby, PO; Reichert, DE; Welch, MJ1
Brechbiel, MW; Chappell, LL; Dadachova, E; Garmestani, K; Ma, D; Milenic, DE; Schlom, J; Yordanov, A1
Das, T; Mukherjee, A; Pandey, U; Pillai, MR; Sarma, HD; Venkatesh, M1
Fisher, DR; Goldenberg, DM; Govindan, SV; Griffiths, GL; Sharkey, RM1
Bernard, BF; Breeman, WA; de Jong, M; Erion, JL; Krenning, EP; van der Wansem, K; van Gameren, A; Visser, TJ1
Jedináková-Krízová, V; Koudelková, M; Vinsová, H1
de Jong, M; de Visser, M; Erion, JL; Janssen, PJ; Krenning, EP; Reubi, JC; Schmidt, MA; Srinivasan, A; Waser, B1
Smith-Jones, PM; Solit, DB1
Anelli, PL; Lattuada, L; Lorusso, V; Lux, G; Morisetti, A; Morosini, P; Serleti, M; Uggeri, F1
Cannara, RJ; Casalbore, P; Crawford, JF; Daniels, MJ; De Stasio, G; Erhardt, RJ; Fowler, JF; Frazer, BH; Gilbert, B; Gilles, MK; Howard, SP; Larocca, LM; Mehta, MP; Mercanti, D; Pallini, R; Rajesh, D; Richter, KL; Schaub, S; Sonderegger, BR; Tyliszczak, T; Wiese, LM1
Albert, R; Bruns, C; Hoyer, D; Kerrad, S; Kneuer, R; Lewis, I; Pless, J; Simeon, C1
Decaudin, D; Ellison, D; Finucane, C; Kadouche, J; Mather, SJ; Sabbah, EN1
Hovinen, J1
Abrahmsén, L; Ahlgren, S; Brechbiel, MW; Hjertman, M; Orlova, A; Sandström, M; Sjöberg, A; Tolmachev, V; Wållberg, H; Xu, H1
Cecchi, A; Innocenti, A; Montero, JL; Rami, M; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY1
Boerman, OC; Brom, M; Gotthardt, M; Joosten, L; Oyen, WJ1
Bigner, DD; Hens, M; Vaidyanathan, G; Zalutsky, MR; Zhao, XG1
De Silva, CR; Hruby, VJ; Josan, JS; Lynch, RM; Pagel, MD; Vagner, J; Yoo, B1
André, JP; Cañada, FJ; Dias, DM; Geraldes, CF; Jiménez-Barbero, J; Martins, JA; Teixeira, JM1
Blange, R; Burdinski, D; de Vries, A; Grüll, H; Hijnen, NM1
Hann, S; Koellensperger, G; Kretschy, D1
Allen, C; Fonge, H; Huang, H; Reilly, RM; Scollard, D1
Blechert, B; Bruchertseifer, F; Essler, M; Gärtner, FC; Morgenstern, A; Neff, F; Seidl, C; Senekowitsch-Schmidtke, R1
Adam, MJ; Bailey, GA; Boros, E; Cawthray, JF; Ferreira, CL; Orvig, C; Price, EW1
Breeman, WA; Chan, HS; de Blois, E; de Zanger, R; Konijnenberg, M1
Bormans, G; Cleynhens, J; Cona, MM; Dyubankova, N; Lescrinier, E; Li, J; Ni, Y; Prinsen, K; Vanbilloen, H; Verbruggen, A1
Burnet, JC; de Araújo, EB; Finucane, C; Foster, JM; Hudson, CD; Mather, SJ; Mengatti, J; Pasqualoto, KFM; Pujatti, PB; Sosabowski, JK1
Ciarmiello, A; Giovacchini, G; Giovannini, E; Riondato, M1
Chen, JL; Li, B; Li, XY; Su, XC1

Reviews

2 review(s) available for pentetic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

ArticleYear
Effectiveness of quenchers to reduce radiolysis of (111)In- or (177)Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC.
    Current topics in medicinal chemistry, 2012, Volume: 12, Issue:23

    Topics: Chelating Agents; Chromatography, High Pressure Liquid; Excipients; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Lutetium; Methionine; Pentetic Acid; Peptides; Protein Stability; Radioactivity; Radiometry; Radiopharmaceuticals

2012
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
    Current radiopharmaceuticals, 2017, Volume: 10, Issue:1

    Topics: Bombesin; Gallium Radioisotopes; Gastrin-Releasing Peptide; Germanium; Heterocyclic Compounds, 1-Ring; Humans; Male; Neuroendocrine Tumors; Pentetic Acid; Phenotype; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed, Single-Photon

2017

Trials

1 trial(s) available for pentetic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

ArticleYear
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:2

    Topics: Antibodies, Monoclonal; Avidin; Biotinylation; Bone Marrow; Chelating Agents; Heterocyclic Compounds, 1-Ring; Humans; Kidney; Liver; Models, Biological; Neoplasms; Pentetic Acid; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Streptavidin; Tomography, Emission-Computed; Urinary Bladder; Whole-Body Counting; Yttrium Radioisotopes

1999

Other Studies

32 other study(ies) available for pentetic acid and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

ArticleYear
Investigations of N-linked macrocycles for 111In and 90Y labeling of proteins.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1992, Volume: 19, Issue:2

    Topics: Amines; Animals; Avidin; Biotin; Chelating Agents; Drug Stability; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Mice; Pentetic Acid; Proteins; Tissue Distribution; Yttrium Radioisotopes

1992
The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1991, Volume: 18, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Bone and Bones; Bone Marrow; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Immunoglobulin G; Isotope Labeling; Ligands; Male; Mice; Mice, Inbred Strains; Pentetic Acid; Yttrium Radioisotopes

1991
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
    British journal of cancer, 1994, Volume: 70, Issue:1

    Topics: Amines; Animals; Antibodies, Monoclonal; Chelating Agents; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Ligands; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Pentetic Acid; Radionuclide Imaging; Recombinant Fusion Proteins; Tissue Distribution; Tumor Cells, Cultured

1994
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3).
    Cancer, 1994, Feb-01, Volume: 73, Issue:3 Suppl

    Topics: Animals; Blood Cell Count; Blood Platelets; Body Weight; Bone Marrow; Chelating Agents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Mice; Mice, Inbred BALB C; Mucins; Pentetic Acid; Radioimmunotherapy; Radiotherapy Dosage; Yttrium Radioisotopes

1994
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
    International journal of cancer, 1998, Jan-30, Volume: 75, Issue:3

    Topics: Animals; Drug Carriers; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Iodine Radioisotopes; Isotope Labeling; Kidney; Male; Mice; Octreotide; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Rats, Wistar; Receptors, Somatostatin; Tissue Distribution; Yttrium Radioisotopes

1998
Molecular modeling of bifunctional chelate peptide conjugates. 1. Copper and indium parameters for the AMBER force field.
    Inorganic chemistry, 2001, Sep-24, Volume: 40, Issue:20

    Topics: Chelating Agents; Copper; Drug Design; Heterocyclic Compounds, 1-Ring; Indium; Models, Chemical; Octreotide; Pentetic Acid; Protein Conformation; Quantitative Structure-Activity Relationship; Radiopharmaceuticals

2001
In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications.
    Nuclear medicine and biology, 2002, Volume: 29, Issue:4

    Topics: Adenocarcinoma; Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Isothiocyanates; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Whole-Body Counting; Xenograft Model Antitumor Assays

2002
Evaluation of 90Y-DTPA and 90Y-DOTA for potential application in intra-vascular radionuclide therapy.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2002, Volume: 57, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Animals; Brachytherapy; Coronary Vessels; Heterocyclic Compounds, 1-Ring; Humans; Kidney; Mice; Pentetic Acid; Radiopharmaceuticals; Stents; Tissue Distribution; Yttrium Radioisotopes

2002
90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Drug Stability; Female; Heterocyclic Compounds, 1-Ring; Humans; In Vitro Techniques; Isotope Labeling; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Radioimmunotherapy; Radiopharmaceuticals; Reference Values; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes

2003
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:2

    Topics: Animals; Bone Marrow; Femur; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Kidney; Lutetium; Male; Octreotide; Organ Specificity; Organometallic Compounds; Pentetic Acid; Radiation-Protective Agents; Radioisotopes; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution

2003
Isotachophoretic determination of stability constants of Ho and Y complexes with diethylenetriaminepentaacetic acid and 1,4,7,10-tetraazadodecane-N,N',N'',N'''-tetraacetic acid.
    Journal of chromatography. A, 2003, Mar-21, Volume: 990, Issue:1-2

    Topics: Electrophoresis; Heterocyclic Compounds, 1-Ring; Holmium; Pentetic Acid; Ytterbium

2003
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:8

    Topics: Animals; Drug Evaluation, Preclinical; Drug Stability; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Neurotensin; Organ Specificity; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Neurotensin; Tissue Distribution; Whole-Body Counting

2003
Generation of DOTA-conjugated antibody fragments for radioimmunoimaging.
    Methods in enzymology, 2004, Volume: 386

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigen-Antibody Reactions; Cell Line, Tumor; Chelating Agents; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Immunoglobulin Fragments; Mammary Neoplasms, Experimental; Mice; Pentetic Acid; Radioimmunodetection; Radioisotopes; Receptor, ErbB-2; Tomography, Emission-Computed; Transplantation, Heterologous; Trastuzumab

2004
Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging.
    Journal of medicinal chemistry, 2004, Jul-01, Volume: 47, Issue:14

    Topics: Animals; Bile Acids and Salts; Chelating Agents; Contrast Media; Female; Gadolinium; Hemodynamics; Hepatocytes; Heterocyclic Compounds, 1-Ring; Lethal Dose 50; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Organometallic Compounds; Pentetic Acid; Rabbits; Rats

2004
Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
    Neurological research, 2005, Volume: 27, Issue:4

    Topics: Animals; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Gadolinium; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mass Spectrometry; Neoplasm Transplantation; Neutron Capture Therapy; Pentetic Acid; Radiography; Radioisotopes; Radionuclide Imaging; Rats; Time Factors; Tissue Distribution

2005
Medicinal chemistry of somatostatin analogs leading to the DTPA and DOTA conjugates of the multi-receptor-ligand SOM230.
    Journal of endocrinological investigation, 2005, Volume: 28, Issue:11 Suppl I

    Topics: Chelating Agents; Heterocyclic Compounds, 1-Ring; Humans; Hydroxyproline; Isotope Labeling; Neoplasms; Pentetic Acid; Receptors, Somatostatin; Somatostatin; Technology, Pharmaceutical; Urethane

2005
In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
    Nuclear medicine and biology, 2007, Volume: 34, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Female; Ferritins; Heterocyclic Compounds, 1-Ring; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Specificity; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution

2007
Labeling of oligonucleotides with DTPA and DOTA on solid phase.
    Nucleosides, nucleotides & nucleic acids, 2007, Volume: 26, Issue:10-12

    Topics: Heterocyclic Compounds, 1-Ring; Oligonucleotides; Pentetic Acid

2007
Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules.
    Bioconjugate chemistry, 2008, Volume: 19, Issue:8

    Topics: Animals; Antibodies; Binding Sites; Cell Line, Tumor; Chelating Agents; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isothiocyanates; Maleimides; Mice; Pentetic Acid; Receptor, ErbB-2; Recombinant Fusion Proteins; Staining and Labeling; Substrate Specificity; Tissue Distribution

2008
Carbonic anhydrase inhibitors: design of membrane-impermeant copper(II) complexes of DTPA-, DOTA-, and TETA-tailed sulfonamides targeting the tumor-associated transmembrane isoform IX.
    ChemMedChem, 2008, Volume: 3, Issue:11

    Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Membrane; Chemistry, Pharmaceutical; Copper; Cytosol; Drug Design; Enzyme Inhibitors; Heterocyclic Compounds, 1-Ring; Humans; Pentetic Acid; Positron-Emission Tomography; Protein Isoforms; Sulfonamides

2008
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:7

    Topics: Amino Acid Sequence; Animals; Biological Transport; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; Injections; Insulinoma; Kinetics; Lysine; Mice; Molecular Sequence Data; Pentetic Acid; Peptides; Positron-Emission Tomography; Rats

2010
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
    Nuclear medicine and biology, 2010, Volume: 37, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; ErbB Receptors; Flow Cytometry; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Isothiocyanates; Lutetium; Mice; Mice, Inbred BALB C; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Stereoisomerism; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010
Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.
    Methods in molecular biology (Clifton, N.J.), 2011, Volume: 716

    Topics: Animals; Binding Sites; Cell Line; Chelating Agents; Fluorescent Dyes; Heterocyclic Compounds, 1-Ring; Humans; Lanthanoid Series Elements; Ligands; Magnetic Resonance Imaging; Mice; Microscopy, Fluorescence; Molecular Imaging; Neoplasms; Pentetic Acid

2011
The interaction of La(3+) complexes of DOTA/DTPA glycoconjugates with the RCA(120) lectin: a saturation transfer difference NMR spectroscopic study.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2011, Volume: 16, Issue:5

    Topics: Contrast Media; Glycoconjugates; Heterocyclic Compounds, 1-Ring; Lanthanum; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Pentetic Acid; Plant Lectins; Protein Binding; Ricinus

2011
Synthesis and in vivo evaluation of 201Tl(III)-DOTA complexes for applications in SPECT imaging.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:4

    Topics: Animals; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Pentetic Acid; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

2011
Stability assessment of different chelating moieties used for elemental labeling of bio-molecules.
    Metallomics : integrated biometal science, 2011, Volume: 3, Issue:12

    Topics: Chelating Agents; Chromatography; Coordination Complexes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Pentetic Acid; Temperature

2011
Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Feb-10, Volume: 157, Issue:3

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Chemistry, Pharmaceutical; Epidermal Growth Factor; Heterocyclic Compounds, 1-Ring; Humans; Mice; Mice, Nude; Micelles; Neoplasm Transplantation; Pentetic Acid; Polymers; Tissue Distribution

2012
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4

    Topics: Actinium; Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kidney; Mice; Organometallic Compounds; Pentetic Acid; Peptides; Peritoneal Neoplasms; Radioisotopes; Treatment Outcome; Xenograft Model Antitumor Assays

2012
H4octapa: an acyclic chelator for 111In radiopharmaceuticals.
    Journal of the American Chemical Society, 2012, May-23, Volume: 134, Issue:20

    Topics: Animals; Chelating Agents; Female; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Mice; Models, Molecular; Pentetic Acid; Radiopharmaceuticals; Thermodynamics; Tissue Distribution

2012
Synthesis and biological evaluation of 68Ga labeled bis-DOTA-3,3'-(benzylidene)-bis-(1H-indole-2-carbohydrazide) as a PET tracer for in vivo visualization of necrosis.
    Bioorganic & medicinal chemistry letters, 2013, Jun-01, Volume: 23, Issue:11

    Topics: Animals; Apoptosis; Coordination Complexes; fas Receptor; Gallium Radioisotopes; Half-Life; Heterocyclic Compounds, 1-Ring; Mice; Necrosis; Pentetic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution

2013
Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2015, Volume: 96

    Topics: Animals; Bombesin; Breast Neoplasms; Cell Line, Tumor; Drug Stability; Female; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; In Vitro Techniques; Indium Radioisotopes; Male; Mice, SCID; Neoplasm Transplantation; Pentetic Acid; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution

2015
Dynamic Exchange of the Metal Chelating Moiety: A Key Factor in Determining the Rigidity of Protein-Tag Conjugates in Paramagnetic NMR.
    The journal of physical chemistry letters, 2020, Nov-05, Volume: 11, Issue:21

    Topics: Binding Sites; Chelating Agents; Coordination Complexes; Heterocyclic Compounds, 1-Ring; Indicators and Reagents; Kinetics; Lanthanoid Series Elements; Ligands; Nuclear Magnetic Resonance, Biomolecular; Pentetic Acid; Protein Binding; Protein Conformation; Ubiquitin

2020